Monday, pharmaceutical companies can start marketing a generic version of Plan B. I hope this will increase access to emergency contraception (EC), but I am skeptical. Part of the problem is a fundamental misunderstanding of how Plan B works (or doesn’t work, for that matter). Part of the problem is the regulatory issues which won’t change just because there’s a generic version.
I’d like to think that clinicians are better informed about EC today, but I’m not sure that’s true everywhere. However, I stumbled across a pretty cool tool that can assist you in putting together a high quality presentation on this topic, should you care to provide some training to staff or colleagues.
